2013. Vemurafenib (PLX4032, Zelboraf®), a BRAF Inhibitor, Modulates ABCB1-, ABCG2-, and ABCC10-Mediated Multidrug Resistance. Journal of Cancer Research Updates. 2, 4 (Nov. 2013),  306–317. DOI:https://doi.org/10.6000/1929-2279.2013.02.04.9.